Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 EUR | -4.46% | -17.41% | -19.28% |
Sales 2024 * | 30.13M 32.63M | Sales 2025 * | 51.2M 55.45M | Capitalization | 264M 286M |
---|---|---|---|---|---|
Net income 2024 * | -39M -42.24M | Net income 2025 * | -23M -24.91M | EV / Sales 2024 * | 9.59 x |
Net Debt 2024 * | 24.7M 26.75M | Net cash position 2025 * | 2.55M 2.76M | EV / Sales 2025 * | 5.11 x |
P/E ratio 2024 * |
-6.38
x | P/E ratio 2025 * |
-6.71
x | Employees | 102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.67% |
Latest transcript on Nanobiotix
1 day | -4.46% | ||
1 week | -17.41% | ||
Current month | -17.41% | ||
1 month | -13.76% | ||
3 months | -10.96% | ||
6 months | +3.28% | ||
Current year | -19.28% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Lévy
CEO | Chief Executive Officer | 53 | 03-03-03 |
Bart van Rhijn
DFI | Director of Finance/CFO | 52 | 21-05-31 |
Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
CHM | Chairman | 58 | 21-05-24 |
Enno Spillner
BRD | Director/Board Member | 55 | 14-06-17 |
Alain Herrera
BRD | Director/Board Member | 74 | 11-06-22 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 5.36 | -4.46% | 90 517 |
24-06-06 | 5.61 | -3.77% | 64,604 |
24-06-05 | 5.83 | -1.02% | 37,410 |
24-06-04 | 5.89 | -8.33% | 120,055 |
24-06-03 | 6.425 | -1.00% | 55,956 |
Real-time Euronext Paris, June 07, 2024 at 09:28 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.28% | 288M | |
+55.55% | 59.28B | |
+42.15% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- NANO Stock